OSI Systems (OSIS) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

OSI Systems

NasdaqGS•Technology•Electronic Components

$200.95+2.05(0.01%)Pre-market

Market Cap

$3.19B

P/E

20.1x

P/S

1.8x

P/B

4.1x

OSI Systems, Inc. designs and manufactures specialized electronic systems and components for critical applications in the United States, Mexico, the rest of Americas, the United Kingdom, Europe, the Middle East, Africa, and the Asia-Pacific. The company offers security products, such as baggage and parcel inspection, cargo and vehicle inspection, hold baggage screening, people screening, radiation monitoring, explosive and narcotics trace detection, and optical inspection systems; turnkey security screening services for enterprise inspection process integration, operator training, and the staffing and operation of security screening checkpoints under the S2 brand. It also provides trace detection systems for trace amounts of explosives and narcotics and people screening products, including walk-through metal detectors for use at security checkpoints at airports, government buildings, sports arenas, and other venues; digital and analog high-power RF systems; and active components for detection of lights of different wavelengths and converts light into electrical signals. In addition, the company offers devices for emitting light in the form of lasers; passive components for amplifying, separating, and reflecting light under the OSI Optoelectronics brand; and printed circuit board assemblies, cable and harness assemblies, and complete systems. Further, it provides bedside monitors, such as the Xprezzon and Qube, as well as telemetry solutions; Spacelabs SafeNSound for assisting hospitals; predictive analytics clinical decision support solutions; Pathfinder SL and Lifescreen Pro analysis tools; and Eclipse Pro Holter recorders. Additionally, the company offers Eclipse Mini Ambulatory ECG recorders; ambulatory blood pressure monitors; Spacelabs OnTrak ambulatory blood pressure systems; Sentinel, a cardiology information management system; and multivendor compatible accessories. OSI Systems, Inc. was incorporated in 1987 and is headquartered in Hawthorne, California.

How this company scores

GoodMetricSide Score: 65/100

Strongest: Cash & Earnings Quality (24/25); weakest: Balance Sheet & Red Flags (9/25).

Profitability19/25

Growth13/25

Balance Sheet & Red Flags9/25

Cash & Earnings Quality24/25

Strengths

Rising free cash flowHigh ROECash-backed earningsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 20.1x5y range 13.2x – 38.4x

Currently near its 20-quarter median.

P/S · 1.8x5y range 1.2x – 2.4x

Currently near its 20-quarter median.

P/B · 4.1x5y range 2.6x – 5.2x

Currently near its 20-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Leverage Risk

Watch

Debt-to-equity has risen 176.1% recently — increasing financial risk even if the current ratio is manageable.

Price & Volume

Market Cap $3.19B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.80B
Q. Revenue: $403.47M
TTM EBITDA: $260.90M
TTM Op. Income: $219.47M
Q. Op. Income: $33.57M
TTM Net Income: $158.73M
Q. Net Income: $24.57M
EPS: $1.55
Shares Out.: $15.90M

$1.80B in TTM revenue grew 2.9% YoY, reaching $403.47M last quarter. TTM EBITDA of $260.90M and TTM operating income of $219.47M show growth is flowing through to the bottom line. TTM net income of $158.73M means revenue is converting into profit. Over the past year, TTM revenue is up 3% — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 30.7%
EBITDA Margin: 10.6%
Op. Margin: 8.3%
Net Margin: 6.1%

Op. margin of 8.3% is down 0.3% YoY — costs are rising relative to revenue. Net margin at 6.1% and gross margin of 30.7% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 3% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 20.1x
P/S Ratio: 1.8x
P/B Ratio: 4.1x

At 20.1x P/E, the stock trades within typical market levels. P/S of 1.8x and P/B of 4.1x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 3 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $2.49B
Cash: $236.30M
Long-Term Debt: $998.29M
Book Value: $782.84M
D/E Ratio: 1.3
Debt/EBITDA: 23.4

With $2.49B in assets and $998.29M in long-term debt, D/E is 1.3and book value is $782.84M — moderate leverage. Across the last 8 quarters, debt/equity has risen for 2 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $37.09M
TTM Free Cash Flow: $264.66M
FCF Margin: 14.7%
FCF / Net Income: 1.7

TTM FCF of $264.66M on $37.09M in operating cash flow. The FCF / Net Income ratio of 1.7x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.